NCT02965976View on ClinicalTrials.gov

Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

December 30, 2016

Primary Completion Date

January 28, 2022

Study Completion Date

April 28, 2022

Conditions
Esophageal Carcinoma
Interventions
BIOLOGICAL

Botulinum Toxin Type A

Given IM

PROCEDURE

Esophagectomy

Undergo esophagectomy

OTHER

Quality-of-Life Assessment

Ancillary studies

Trial Locations (1)

14263

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT02965976 - Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal Cancer | Biotech Hunter | Biotech Hunter